Browsing by Sponsor/Funder Karyopharm
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Jun-2021 | Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma | Mateos, MV; Gavriatopoulou, M; Facon, T; Auner, HW; Leleu, X, et al |
| 14-Nov-2020 | Once-weekly selinexor, bortezomib, and dexamethasone versus twice-weekly bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label phase 3 trial | Grosicki, S; Simonova, M; Spicka, I; Pour, L; Kriachok, I, et al |
| 1-Oct-2021 | Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone | Sanchez, L; Leleu, X; Beaumont, JL; Yu, H; Hudgens, S, et al |